Genetic variation in sex hormone receptor genes and association with enzalutamide response in metastatic castration-resistant prostate cancer (mCRPC).

e16606Background: Enzalutamide has been shown to prolong overall survival in men with mCRPC. Given the modest response rate, high cost, and availability of alternative treatment options, it is cruc...